Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NAMPT inhibitors(Nicotinamide phosphoribosyltransferase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H22ClN5O |
InChIKeyBOIPLTNGIAPDBY-UHFFFAOYSA-N |
CAS Registry200484-11-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | CH | 01 Apr 1999 | |
Solid tumor | Phase 2 | NL | 01 Apr 1999 | |
Solid tumor | Phase 2 | DK | 01 Apr 1999 | |
Solid tumor | Phase 2 | DE | 01 Apr 1999 | |
Solid tumor | Phase 2 | GB | 01 Apr 1999 | |
Solid tumor | Phase 2 | BE | 01 Apr 1999 | |
Solid tumor | Phase 2 | NO | 01 Apr 1999 | |
Lymphoma | Phase 2 | - | - | |
Lymphoma | Phase 2 | - | - | |
Neoplasms | Phase 2 | - | - |